Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Ventas, Inc.    VTR

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 
Latest news on VENTAS, INC.
03/22 VENTAS : Announces Pricing of Senior Notes
03/15 VENTAS : Chicago firm buys South Street Landing for $130 million
03/14 VENTAS : Acquires High-Quality Life Science, Research and Medical Campus, Adding..
03/14 VENTAS : Completes Secured Debt Financing for Ardent Health Services’ Acqu..
03/06 VENTAS : Chairman and CEO Debra A. Cafaro Honored by Modern Healthcare as One of..
03/06 VENTAS : to Participate in Citi 2017 Global Property CEO Conference
03/03 VENTAS, INC. : Post Earnings Coverage as Ventas Quarterly Revenue Grew 4.1%, Ann..
03/03 VENTAS, INC. : ex-dividend day
02/16DJVentas In Talks to Buy Part or All of Brookdale Senior Living -- Update
02/16DJVentas In Talks to Buy Part or All of Brookdale Senior Living
02/14 VENTAS INC : Other Events, Financial Statements and Exhibits (form 8-K)
02/14 VENTAS,INC. (NYSE : VTR) Files An 8-K Other Events
02/14 VENTAS : Management's Discussion and Analysis of Financial Condition and Results..
02/10 VENTAS : VTR) Falls Ahead of Earnings
02/10 VENTAS : reports 4Q results
02/10 VENTAS INC : Results of Operations and Financial Condition, Other Events, Financ..
02/10 VENTAS : Reports 2016 Fourth Quarter and Full-Year Results
02/08 VENTAS : Research Reports Initiation on REIT Stocks -- HCP Inc., Medical Propert..
01/25 VENTAS, INC. (NYSE : VTR) Files An 8-K Departure of Directors or Certain O..
01/24 VENTAS INC : Change in Directors or Principal Officers (form 8-K)
01/18 VENTAS : Announces Tax Treatment of 2016 Distributions
01/11 VENTAS INC : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Fi..
01/10 VENTAS, INC. (NYSE : VTR) Files An 8-K Regulation FD Disclosure
01/10 VENTAS INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8..
01/10 VENTAS : Comments on Full Year 2016 Expectations and Issues Preliminary 2017 Out..
2016 VENTAS : Technical Reports on REIT Stocks -- Medical Properties Trust, HCP Inc.,..
2016 VENTAS, INC. : ex-dividend day
2016 VENTAS : Increases Fourth Quarter 2016 Dividend by 6 Percent
2016 VENTAS : CEO to Participate in Harvard Business Review's Top 100 CEOs Panel Disc..
2016 VENTAS : CEO to Participate in Harvard Business Review’s Top 100 CEOs Pane..
2016 KINDRED HEALTHCARE, INC (NYSE : KND) Files An 8-K Announces Agreements With Vent..
2016 VENTAS : Announces Agreements With Kindred Healthcare to Facilitate Kindred&rsqu..
2016 VENTAS INC. : (VTR) Falls 4.07% for November 09
2016 VENTAS INC. : (VTR) is Trading Lower on Unusual Volume for November 08
2016 VENTAS : Time To Buy Ventas Already
2016 VENTAS : Comments on Kindred Healthcare Exit from Skilled Nursing Facility Busin..
2016 VENTAS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
2016 VENTAS : reports 3Q results
2016 VENTAS INC : Results of Operations and Financial Condition, Financial Statements..
2016DJVENTAS : Boosts Outlook as Profit Soars
2016 VENTAS : Reports 2016 Third Quarter Results
2016 VENTAS : REIT Stocks Technical Reports -- Medical Properties Trust, HCP Inc., Ve..
2016 VENTAS : Pggm Investments buys $260,580,392 stake in Ventas
2016DJVENTAS : REITs Focused On Health Care Back Off Nursing -- WSJ
2016DJVENTAS : Health-Care REITs Back Off Nursing
2016 VENTAS : Announces Third Quarter 2016 Earnings Release Date and Conference Call
2016 VENTAS : Issues Secured Debt Financing Commitment for Ardent Health Services to ..
2016 ARDENT HEALTH SERVICES : And LHP Hospital Group, Inc. Announce Plans To Merge
2016 KINDRED HEALTHCARE : Completes Sale of 12 LTAC Hospitals to Curahealth
2016 VENTAS INC : Other Events (form 8-K)
2016 VENTAS INC : Other Events, Financial Statements and Exhibits (form 8-K)
2016DJVENTAS : Ernst & Young to Pay $9.3 Million to Settle Charges
2016 VENTAS : Can Be Used To Generate 12% To 17% Engineered Income
2016 VENTAS : Announces Pricing of Senior Notes Offering
2016 VENTAS, INC. : ex-dividend day
2016 VENTAS : Wexford Science & Technology to Become an Independent Company
2016 VENTAS : Completes Acquisition of Wexford’s Life Science and Medical Real ..
2016 VENTAS : Declares Regular Quarterly Dividend of $0.73 Per Share
2016 VENTAS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
2016DJVENTAS : Profit Falls Less Than Expected
2016 VENTAS : reports 2Q results
2016 VENTAS INC : Results of Operations and Financial Condition, Financial Statements..
2016 VENTAS : Reports 2016 Second Quarter Results
2016VENTAS, INC. : half-yearly earnings release
2016 VENTAS INC : Other Events, Financial Statements and Exhibits (form 8-K)
2016 VENTAS : Announces Second Quarter 2016 Earnings Release Date and Conference Call
2016 VENTAS : REIT acquires Wexford assets
2016 VENTAS : Blackstone sells properties of Baltimore biopark developer for $1.5 bil..
2016 VENTAS : to acquire South Street Landing investor Wexford for $1.5 billion
2016 VENTAS : to Acquire Life Science and Medical Real Estate Assets of Wexford for $..
2016 VENTAS : to Acquire High-Quality Life Science and Medical Real Estate Leased By ..
2016 BRIEF : Ventas to acquire Wexford's real estate
2016 VENTAS : Announces Pricing of Common Stock Offering
2016DJVentas Signs $1.5 Billion Life Sciences-Focused Deal
2016 VENTAS : Announces Public Offering of 9,000,000 Shares of Common Stock
1  2  3  4  5  6Next
Advertisement
Financials ($)
Sales 2017 3 550 M
EBIT 2017 863 M
Net income 2017 626 M
Debt 2017 11 119 M
Yield 2017 4,83%
P/E ratio 2017 29,30
P/E ratio 2018 35,40
EV / Sales 2017 9,59x
EV / Sales 2018 9,39x
Capitalization 22 941 M
More Financials
Chart VENTAS, INC.
Duration : Period :
Ventas, Inc. Technical Analysis Chart | VTR | US92276F1003 | 4-Traders
Full-screen chart
Technical analysis trends VENTAS, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 19
Average target price 62,4 $
Spread / Average Target -3,6%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Debra A. Cafaro Chairman & Chief Executive Officer
Robert F. Probst Chief Financial Officer & Executive Vice President
John K. Hart Chief Information Officer & Senior Vice President
Jay M. Gellert Independent Director
James D. Shelton Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
VENTAS, INC.3.47%22 941
WELLTOWER INC5.50%25 646
HCP, INC.4.31%14 521
OMEGA HEALTHCARE INVES..4.89%6 451
HEALTHCARE TRUST OF AM..7.76%4 447
MEDICAL PROPERTIES TRU..3.50%4 085
More Results